Opaleye Management Inc. - Net Worth and Insider Trading

Over the past 18 months, Opaleye Management Inc. made no insider transaction in Eton Pharmaceuticals Inc (ETON). Other recent insider transactions involving Eton Pharmaceuticals Inc (ETON) include a net purchase of 10,000 shares made by Sean Brynjelsen ,

In summary, during the past 3 months, insiders sold 0 shares of Eton Pharmaceuticals Inc (ETON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eton Pharmaceuticals Inc (ETON) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.

Eton Pharmaceuticals Inc (ETON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Opaleye Management Inc. made 4 insider transaction in Protara Therapeutics Inc (TARA) with a net purchase of 28,699. Other recent insider transactions involving Protara Therapeutics Inc (TARA) include a net purchase of 10,000 shares made by Luke M Beshar , a net purchase of 9,065 shares made by Jesse Shefferman ,

In summary, during the past 3 months, insiders sold 0 shares of Protara Therapeutics Inc (TARA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,473 shares of Protara Therapeutics Inc (TARA) were sold and 63,237 shares were bought by its insiders, resulting in a net purchase of 47,764 shares.

Protara Therapeutics Inc (TARA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Opaleye Management Inc. made 19 insider transaction in TRACON Pharmaceuticals Inc (TCON) with a net purchase of 1,387,871. Other recent insider transactions involving TRACON Pharmaceuticals Inc (TCON) include a net purchase of 168,399 shares made by Charles Theuer , a net purchase of 7,000 shares made by Scott B. Brown , and a net sale of 120 shares made by William R Larue .

In summary, during the past 3 months, insiders sold 0 shares of TRACON Pharmaceuticals Inc (TCON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,659 shares of TRACON Pharmaceuticals Inc (TCON) were sold and 1,564,809 shares were bought by its insiders, resulting in a net purchase of 1,563,150 shares.

TRACON Pharmaceuticals Inc (TCON)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Opaleye Management Inc. made 4 insider transaction in Harrow Health Inc (HROW) with a net purchase of 503,657. Other recent insider transactions involving Harrow Health Inc (HROW) include a net purchase of 45,000 shares made by Martin A. Makary , a net purchase of 30,800 shares made by Mark L Baum , and a net sale of 40,000 shares made by Lindstrom Richard L Md .

In summary, during the past 3 months, insiders sold 0 shares of Harrow Health Inc (HROW) in total and bought 45,800 shares, with a net purchase of 45,800 shares. During the past 18 months, 40,000 shares of Harrow Health Inc (HROW) were sold and 583,817 shares were bought by its insiders, resulting in a net purchase of 543,817 shares.

Harrow Health Inc (HROW)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Opaleye Management Inc. made no insider transaction in Ocular Therapeutix Inc (OCUL). Other recent insider transactions involving Ocular Therapeutix Inc (OCUL) include a net purchase of 177,328 shares made by Summer Road Llc , a net sale of 13,169 shares made by Antony C. Mattessich , and a net sale of 7,248 shares made by Rabia Gurses Ozden .

In summary, during the past 3 months, insiders sold 832 shares of Ocular Therapeutix Inc (OCUL) in total and bought 6,500 shares, with a net purchase of 5,668 shares. During the past 18 months, 45,403 shares of Ocular Therapeutix Inc (OCUL) were sold and 198,828 shares were bought by its insiders, resulting in a net purchase of 153,425 shares.

Ocular Therapeutix Inc (OCUL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Opaleye Management Inc. made 15 insider transaction in TELA Bio Inc (TELA) with a net purchase of 460,287. Other recent insider transactions involving TELA Bio Inc (TELA) include a net purchase of 800,170 shares made by Ew Healthcare Partners Fund 2-a, L.p. , a net sale of 192,000 shares made by Orbimed Advisors Llc , and a net purchase of 15,000 shares made by Roberto Cuca .

In summary, during the past 3 months, insiders sold 0 shares of TELA Bio Inc (TELA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 192,000 shares of TELA Bio Inc (TELA) were sold and 1,275,457 shares were bought by its insiders, resulting in a net purchase of 1,083,457 shares.

TELA Bio Inc (TELA)'s detailed insider trading history can be found in Insider Trading Tracker table.